Incyte Corp (NASDAQ:INCY)

77.69
Delayed Data
As of Jul 01
 +1.72 / +2.26%
Today’s Change
61.91
Today|||52-Week Range
84.86
+5.84%
Year-to-Date
3 Bargain Stocks Near 52-Week Lows to Buy and Forget
Jun 29 / StockNews.com - Paid Partner Content
3 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget
Jun 26 / MotleyFool.com - Paid Partner Content
5 High-Performing Cathie Wood Stocks as of June
Jun 28 / GuruFocus News - Paid Partner Content
Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion
Jun 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close75.97
Today’s open75.45
Day’s range75.43 - 77.86
Volume83,853
Average volume (3 months)1,432,055
Market cap$17.2B
Data as of 3:59pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-50.37%
Earnings growth (next 5 years)+25.46%
Revenue growth (last year)+11.98%
P/E ratio18.5
Price/Sales5.46
Price/Book4.55

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+2.42+1.66%
HZNPHorizon Therapeutics...+1.07+1.34%
CTLTCatalent Inc-0.31-0.29%
VTRSViatris Inc+0.23+2.24%
Data as of 4:00pm ET, 07/01/2022

Financials

Next reporting dateAugust 2, 2022
EPS forecast (this quarter)$0.54
Annual revenue (last year)$3.0B
Annual profit (last year)$948.6M
Net profit margin31.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Wilmington, Delaware

Forecasts